Naloxone does not benefit levodopa-induced hallucinations in Parkinson's disease.
D000368:Aged; D005260:Female; D006212:Hallucinations / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009270:Naloxone / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000150:complications*
D009270:Naloxone